Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakob Passweg

Showing results (11-20 of 320) with videos related to

Pageof 32
Sort By:
Annals of Hematology|March 28, 2015
The role of hematopoietic stem cell transplantation in chronic myeloid leukemiaAlois Gratwohl, Helen Baldomero, Jakob Passweg
Annals of Hematology|June 3, 2021
Incidence and impact of Epstein-Barr virus events in the early phase after allogeneic hematopoietic cell transplantationSamuel Macy, Jakob Passweg, Michael Medinger
Leukemia Research Reports|October 19, 2016
Novel therapeutic options in Acute Myeloid LeukemiaMichael Medinger, Claudia Lengerke, Jakob Passweg
Pediatric Research|March 21, 2012
Complications of autologous hematopoietic stem cell transplantation for patients with autoimmune diseasesThomas Daikeler, André Tichelli, Jakob Passweg
Current Problems in Dermatology|March 2, 2012
Future trends in hematopoietic stem cell transplantationJörg Halter, Jakob Passweg, Peter Häusermann
Current Opinion in Hematology|October 10, 2013
Hematopoietic stem cell transplantation activity in EuropeAlois Gratwohl, Helen Baldomero, Jakob Passweg
Leukemia Research Reports|August 4, 2021
Influence of HLA-DPB1 mismatches on outcome after allogeneic hematopoietic stem cell transplantationMireille Hunziker, Jakob Passweg, Michael Medinger
Science and Engineering Ethics|October 25, 2017
Obstacles to Widening Biosample ResearchFlora Colledge, Jakob Passweg, Bernice Elger
Cell Transplantation|November 9, 2010
Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activityAmandine Pradier, Jakob Passweg, Jean Villard, et al.
Medecine Sciences : M/S|January 22, 2009
[APRIL, the spring of plasmacytes]Maka Burjanadze, Eddy Roosnek, Jakob Passweg, et al.
Pageof 32

Showing results (11-20 of 320) with videos related to

Sort By:
Pageof 32
Annals of Hematology|March 28, 2015
The role of hematopoietic stem cell transplantation in chronic myeloid leukemiaAlois Gratwohl, Helen Baldomero, Jakob Passweg
Annals of Hematology|June 3, 2021
Incidence and impact of Epstein-Barr virus events in the early phase after allogeneic hematopoietic cell transplantationSamuel Macy, Jakob Passweg, Michael Medinger
Leukemia Research Reports|October 19, 2016
Novel therapeutic options in Acute Myeloid LeukemiaMichael Medinger, Claudia Lengerke, Jakob Passweg
Pediatric Research|March 21, 2012
Complications of autologous hematopoietic stem cell transplantation for patients with autoimmune diseasesThomas Daikeler, André Tichelli, Jakob Passweg
Current Problems in Dermatology|March 2, 2012
Future trends in hematopoietic stem cell transplantationJörg Halter, Jakob Passweg, Peter Häusermann
Current Opinion in Hematology|October 10, 2013
Hematopoietic stem cell transplantation activity in EuropeAlois Gratwohl, Helen Baldomero, Jakob Passweg
Leukemia Research Reports|August 4, 2021
Influence of HLA-DPB1 mismatches on outcome after allogeneic hematopoietic stem cell transplantationMireille Hunziker, Jakob Passweg, Michael Medinger
Science and Engineering Ethics|October 25, 2017
Obstacles to Widening Biosample ResearchFlora Colledge, Jakob Passweg, Bernice Elger
Cell Transplantation|November 9, 2010
Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activityAmandine Pradier, Jakob Passweg, Jean Villard, et al.
Medecine Sciences : M/S|January 22, 2009
[APRIL, the spring of plasmacytes]Maka Burjanadze, Eddy Roosnek, Jakob Passweg, et al.
Pageof 32